However, this radiation-induced antitumor immunity is insufficient for destroying tumors, and the tumor frequently regrew because of PD-L1 upregulation by tumor and myeloid cells and PD-1 downregulation by CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.